AR128011A1 - Polinucleótidos, polipéptidos de aciltransferasa modificados, y sus métodos de uso - Google Patents
Polinucleótidos, polipéptidos de aciltransferasa modificados, y sus métodos de usoInfo
- Publication number
- AR128011A1 AR128011A1 ARP220103486A ARP220103486A AR128011A1 AR 128011 A1 AR128011 A1 AR 128011A1 AR P220103486 A ARP220103486 A AR P220103486A AR P220103486 A ARP220103486 A AR P220103486A AR 128011 A1 AR128011 A1 AR 128011A1
- Authority
- AR
- Argentina
- Prior art keywords
- motif
- modified
- formula
- protein
- dgat1
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000040430 polynucleotide Human genes 0.000 title abstract 3
- 108091033319 polynucleotide Proteins 0.000 title abstract 3
- 239000002157 polynucleotide Substances 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102100036869 Diacylglycerol O-acyltransferase 1 Human genes 0.000 abstract 7
- 101000927974 Homo sapiens Diacylglycerol O-acyltransferase 1 Proteins 0.000 abstract 7
- 210000004027 cell Anatomy 0.000 abstract 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 235000018102 proteins Nutrition 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000004475 Arginine Substances 0.000 abstract 1
- 239000004471 Glycine Substances 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical group C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- 235000004279 alanine Nutrition 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 abstract 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000004897 n-terminal region Anatomy 0.000 abstract 1
- 238000011144 upstream manufacturing Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
- C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/0102—Diacylglycerol O-acyltransferase (2.3.1.20)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La invención proporciona un método para producir una proteína DGAT1 modificada, el método comprende la manipulación dirigida de al menos un motivo seleccionado de entre: a) un motivo de la fórmula seleccionada entre RR, RXR y RXXR, b) un motivo de la fórmula AXXXA, c) un motivo de la fórmula AXXXG, d) un motivo de la fórmula GXXXG, y e) un motivo de la fórmula GXXXA, en la región N-terminal de la proteína en sentido ascendente con respecto al sitio de unión acil-CoA de una proteína DGAT1, donde R es arginina, alanina, G es glicina y X es cualquier aminoácido. La proteína DGAT1 modificada puede expresarse en una célula u organismo, particularmente en una planta, para aumentar la producción de lípidos en la célula u organismo, particularmente en una planta. La invención también proporciona la proteína DGAT1 modificada, polinucleótidos que codifican las proteínas DGAT1 modificadas, células y composiciones que comprenden los polinucleótidos o proteínas DGAT1 modificadas, y los métodos que utilizan las proteínas DGAT1 modificadas para producir aceite.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2021904092A AU2021904092A0 (en) | 2021-12-16 | Modified acyltransferase polynucleotides, polypeptides, and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR128011A1 true AR128011A1 (es) | 2024-03-20 |
Family
ID=86773768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220103486A AR128011A1 (es) | 2021-12-16 | 2022-12-16 | Polinucleótidos, polipéptidos de aciltransferasa modificados, y sus métodos de uso |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN118414430A (es) |
| AR (1) | AR128011A1 (es) |
| CA (1) | CA3242467A1 (es) |
| WO (1) | WO2023111871A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014068439A2 (en) * | 2012-10-30 | 2014-05-08 | Agresearch Limited | Improved acyltransferase polynucleotides, polypeptides, and methods of use |
| US11312971B2 (en) * | 2012-10-30 | 2022-04-26 | Agresearch Limited | Enhanced acyltransferase polynucleotides, polypeptides and methods of use |
| WO2019232182A1 (en) * | 2018-06-01 | 2019-12-05 | Pioneer Hi-Bred International, Inc. | Modified seed oil content by gene editing |
-
2022
- 2022-12-14 WO PCT/IB2022/062175 patent/WO2023111871A1/en active Application Filing
- 2022-12-14 CA CA3242467A patent/CA3242467A1/en active Pending
- 2022-12-14 CN CN202280083376.6A patent/CN118414430A/zh active Pending
- 2022-12-16 AR ARP220103486A patent/AR128011A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3242467A1 (en) | 2023-06-22 |
| CN118414430A (zh) | 2024-07-30 |
| WO2023111871A1 (en) | 2023-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR125326A2 (es) | Composiciones de neisseria meningitidis y métodos de las mismas | |
| GT201300295A (es) | "composiciones que contienen, metodos que involucran, y usos de derivados de dolastatina unidos a aminoacidos no naturales" | |
| BR112017008108A2 (pt) | incorporação de aminoácidos não naturais em proteínas | |
| AR075186A1 (es) | Plantas que tienen mejores rasgos relacionados con el rendimiento y un metodo para producirlas | |
| PE20140867A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
| CO2020009402A2 (es) | Proteínas de fusión fc il-22 y métodos de uso | |
| AR049308A1 (es) | Moleculas de acido nucleico que codifican polipeptidos tipo wrinkled 1 y metodos de uso en plantas | |
| BR122021020829B8 (pt) | Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada | |
| AR065121A1 (es) | Plantas con rasgos aumentados relacionados con el rendimiento y/o resistencia incrementada al estres abiotico y un metodo para desarrollar las mismas | |
| ATE544775T1 (de) | Peptide mit pharmakologischer aktivität zur behandlung von krankheiten die mit veränderter zellmigration assoziiert sind, wie krebs | |
| AR065552A1 (es) | Plantas con rasgos aumentados relacionados con el rendimiento y un metodo para producirlas | |
| EA201590611A1 (ru) | Новые молекулы, связывающие il-17a, и их медицинское применение | |
| AR102445A1 (es) | COMPOSICIONES Y MÉTODOS RELACIONADOS CON b-GLUCOSIDASA | |
| AR084726A1 (es) | Metodos para aumentar el rendimiento y la produccion de productos quimicos finos en plantas | |
| BR112022008092A2 (pt) | Métodos de preparação de uma amostra enriquecida para sequenciamento polipeptídico | |
| AR054158A1 (es) | Plantas con rendimiento aumentado y un metodo para prepararlo | |
| CO2023013171A2 (es) | Composiciones que comprenden un polipéptido variante y usos de las mismas | |
| ECSP17075380A (es) | Fusiones de variante iii del receptor de factor de crecimiento epidérmico-mesotelina y métodos para usar los mismos | |
| AR093290A1 (es) | Polinucleotidos, polipeptidos mejorados de aciltransferasa y sus metodos de uso | |
| AR093289A1 (es) | Polinucleotidos, polipeptidos mejorados de aciltransferasa y sus metodos de uso | |
| CL2022002897A1 (es) | Polipéptidos variantes proteolíticamente estables de u1-agatoxina- ta1b para el control de plagas | |
| BR112014020852A2 (pt) | gene da sintase de hidrocarboneto e uso do mesmo | |
| AR128011A1 (es) | Polinucleótidos, polipéptidos de aciltransferasa modificados, y sus métodos de uso | |
| AR071624A1 (es) | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas mediante la expresion de un acido nucleico que codifica dna proteasa especifica de ubiquitina (ubp) de origen vegetal (ej. oryza) | |
| NZ594481A (en) | Truncated cystine-knot proteins |